Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 17th May 2021 14:38

(Sharecast News) - Diploma: Numis upgrades to add with a target price of 3,250p.

Marshalls: Berenberg reiterates hold with a target price of 790p.

Sabre Insurance Group: Berenberg reiterates hold with a target price of 257p.

Cerillion: Canaccord reiterates buy with a target price of 665p.

Sage: Canaccord reiterates buy with a target price of 700p.

Diploma: Jefferies reiterates hold with a target price of 2,300p.

Vistry Group: Jefferies reiterates buy with a target price of 1,484p.

Diageo: Goldman Sachs reiterates buy with a target price of 3,800p.

AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p.

Sage: JP Morgan upgrades to neutral with a target price of 630p.

Just Eat: JP Morgan reiterates neutral with a target price of 9,676p.

SSP: Citigroup upgrades to neutral with a target price of 1,554p.

3i Group: Credit Suisse reiterates outperform with a target price of 1,420p.

Hyve Group: Liberum upgrades to buy with a target price of 140p.

Mears Group: Liberum reiterates hold with a target price of 190p.

Related Shares

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.